Kapidex Related Clinical Trials
Dexilant Treatment in Gastrointestinal Reflux Disease (GERD Related Non Cardiac Chest Pain [Withdrawn]
Bioavailability, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets in Healthy Participants [Completed]
Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months [Not yet recruiting]
Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis [Completed]
Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis [Completed]
Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux Disease [Completed]
Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents [Completed]
Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis [Completed]
Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis [Completed]
Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn [Completed]
Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis [Completed]
Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn [Completed]
Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease [Completed]
Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer [Completed]
Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn [Completed]
Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents [Completed]
Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease [Completed]
A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants. [Completed]
Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime Heartburn [Completed]
Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency Ablation [Recruiting]
Lansoprazole for Subgroups of Functional Dyspepsia [Terminated]
Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate] [Completed]
Effect of Dexlansoprazole on Bone Homeostasis [Completed]
Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease [Recruiting]
Takepron Intravenous 30 mg Specified Drug-use Survey [Acute Stress Ulcer and Acute Gastric Mucosal Lesions] [Completed]
Efficacy and Safety of Vonoprazan Compared to Lansoprazole in the Maintenance Treatment of Erosive Esophagitis [Recruiting]
Safety and Efficacy of Lansoprazole in Patients With Reflux Disease [Completed]
A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers [Terminated]
The Effects of Dexlansoprazole for the Treatment of Throat-Related Reflux [Terminated]
Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor Therapy [Completed]
Lansoprazole Tablets Special Drug Use Surveillance Gastroesophageal Reflux Disease With Dyspepsia Symptoms [Completed]
Bioequivalence Study of Lansoprazole DR Capsules 30 mg in Fasting Conditions [Completed]
Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets [Completed]
Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed [Completed]
The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 Diabetes [Not yet recruiting]
Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs [Completed]
A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease. [Completed]
A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux Disease [Completed]
Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin [Completed]
Lansoprazole in Preterm Infants With Reflux [Completed]
A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA) [Completed]
Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Erosive Esophagitis [Completed]
A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn [Completed]
Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes [Active, not recruiting]
An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux Esophagitis [Completed]
Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD) [Completed]
Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy [Not yet recruiting]
The Effect of Lansoprazole in Combination With Ecabet Sodium for Gastroesophageal Reflux Disease [Completed]
Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric Ulcer [Completed]
Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer [Completed]
Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Patients With Erosive Esophagitis [Recruiting]
Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn [Completed]
Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Maintenance Treatment of Healed Erosive Esophagitis [Completed]
A Randomized, Open-Label, Comparative 3-Way Treatment Crossover Study of 24-Hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40mg, Lansoprazole 30mg, and Pantoprazole 40mg at Steady State in NSAID-Using Patients [Completed]
Lansoprazole 30 mg DR Capsule Fasting Study [Completed]
Comparison of the Efficacy for Stress Ulcer Prophylaxis Between the Patients Received Lansoprazole OD and Control Group Weaning From Mechanical Ventilator in Respiratory Care Center: a Randomized Control Trial [Completed]
Lansoprazole 30 mg DR Capsule Replicate Food Study [Completed]
Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study [Completed]
The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux [Completed]
A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis [Completed]
Efficacy of Lansoprazole in Chronic Post Nasal Drip [Completed]
Lansoprazole Versus Mosapride for Functional Dyspepsia [Completed]
Proof of Concept Study Efficacy of an Antacid/Lansoprazole Combination for Relief of Heartburn [Completed]
Safety and Efficacy of Lansoprazole 30mg Twice Daily in Treatment of Laryngitis Associated With Gastroesophageal Reflux [Terminated]
Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of Clopidogrel [Completed]
Pharmacokinetic Study of Lansoprazole in Cystic Fibrosis [Completed]
Open-label PK Study to Evaluate Lansoprazole and Neratinib in Healthy Subjects [Completed]
Study Evaluating The Potential Effect Of Lansoprazole On The Pharmacokinetics Of Bosutinib In Healthy Subjects [Completed]
Treatment of Zollinger-Ellison Syndrome With Prevacid [Completed]
Lansoprazole to Treat Children With Asthma [Completed]
Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux [Completed]
Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin [Completed]
Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID) [Completed]
An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients [Completed]
Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn [Completed]
Comparison of Prilosec Over-the-counter (OTC)® Versus Prevacid® for Gastric Acid Suppression [Completed]
Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis [Completed]
Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. Pylori [Completed]
Effects of Lansoprazole on Sitagliptin Glucose-lowering Ability in Healthy Males: a Randomised Crossover Study [Completed]
Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER) [Completed]
Prevacid vs Lifestyle Modifications for the Treatment of LPR [Recruiting]
Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive Heartburn [Completed]
Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin [Completed]
Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD [Completed]
Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID) [Completed]
Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects [Completed]
Evaluation of Methods for the Determination of Chromogranin A in Routine Blood Samples [Completed]
Evaluating Treatment Response in Laryngo-Pharyngeal Reflux [Not yet recruiting]
Lansoprazole Preventing Gastroduodenal Stress Ulcerations [Terminated]
Study to Compare Gastric Inhibition of Two Proton Pump Inhibitors (CL2008-18)(P07815)(COMPLETED) [Completed]
PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers [Recruiting]
Study of Anti-reflux Medication as a Potential Treatment for Glue Ear in Children [Completed]
Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation? [Completed]
Dietary Control Alone Versus Dietary Control Plus Use of Proton Pump Inhibitors to Treat Pediatric Hoarseness [Terminated]
A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin [Completed]
A Clinical Trial of Proton Pump Inhibitors to Treat Children With Chronic Otitis Media With Effusion [Completed]
Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy [Withdrawn]
A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy. [Active, not recruiting]
|